These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17324393)

  • 1. Increased arylsulfatase B activity in cystic fibrosis cells following correction of CFTR.
    Bhattacharyya S; Look D; Tobacman JK
    Clin Chim Acta; 2007 May; 380(1-2):122-7. PubMed ID: 17324393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of proteoglycan production by intrahepatic biliary epithelial cells bearing defective (delta-f508) cystic fibrosis transmembrane conductance regulator.
    Bhaskar KR; Turner BS; Grubman SA; Jefferson DM; LaMont JT
    Hepatology; 1998 Jan; 27(1):7-14. PubMed ID: 9425910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CFTR modifiers on arylsulfatase B activity in cystic fibrosis and normal human bronchial epithelial cells.
    Bhattacharyya S; Feferman L; Tobacman JK
    Pulm Pharmacol Ther; 2016 Feb; 36():22-30. PubMed ID: 26656789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal spatial diffusion of Ca2+ in F508del-CFTR airway epithelial cells.
    Antigny F; Norez C; Cantereau A; Becq F; Vandebrouck C
    Respir Res; 2008 Oct; 9(1):70. PubMed ID: 18973672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing.
    Liu X; Jiang Q; Mansfield SG; Puttaraju M; Zhang Y; Zhou W; Cohn JA; Garcia-Blanco MA; Mitchell LG; Engelhardt JF
    Nat Biotechnol; 2002 Jan; 20(1):47-52. PubMed ID: 11753361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does deficiency of arylsulfatase B have a role in cystic fibrosis?
    Tobacman JK
    Chest; 2003 Jun; 123(6):2130-9. PubMed ID: 12796199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis and related diseases of the pancreas.
    Naruse S; Kitagawa M; Ishiguro H; Fujiki K; Hayakawa T
    Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):511-26. PubMed ID: 12079272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis.
    Dormer RL; Harris CM; Clark Z; Pereira MM; Doull IJ; Norez C; Becq F; McPherson MA
    Thorax; 2005 Jan; 60(1):55-9. PubMed ID: 15618584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suitability of oligonucleotide-mediated cystic fibrosis gene repair in airway epithelial cells.
    de Semir D; Nadal M; González JR; Larriba S; Avinyó A; Nunes V; Casals T; Estivill X; Aran JM
    J Gene Med; 2003 Jul; 5(7):625-39. PubMed ID: 12825202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone.
    Le Heron L; Guillaume C; Velard F; Braux J; Touqui L; Moriceau S; Sermet-Gaudelus I; Laurent-Maquin D; Jacquot J
    J Cyst Fibros; 2010 Jan; 9(1):69-72. PubMed ID: 20005786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early bronchial inflammation in cystic fibrosis].
    Puchelle E
    J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway.
    Zhang LN; Karp P; Gerard CJ; Pastor E; Laux D; Munson K; Yan Z; Liu X; Godwin S; Thomas CP; Zabner J; Shi H; Caldwell CW; Peluso R; Carter B; Engelhardt JF
    Mol Ther; 2004 Dec; 10(6):990-1002. PubMed ID: 15564131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CFTR gene transfer to human cystic fibrosis pancreatic duct cells using a Sendai virus vector.
    Rakonczay Z; Hegyi P; Hasegawa M; Inoue M; You J; Iida A; Ignáth I; Alton EW; Griesenbach U; Ovári G; Vág J; Da Paula AC; Crawford RM; Varga G; Amaral MD; Mehta A; Lonovics J; Argent BE; Gray MA
    J Cell Physiol; 2008 Feb; 214(2):442-55. PubMed ID: 17654517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct interaction of a small-molecule modulator with G551D-CFTR, a cystic fibrosis-causing mutation associated with severe disease.
    Pasyk S; Li C; Ramjeesingh M; Bear CE
    Biochem J; 2009 Feb; 418(1):185-90. PubMed ID: 18945216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
    Kerem E
    Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by TNF-alpha and IL-4 of cationic lipid mediated gene transfer in cystic fibrosis tracheal gland cells.
    Bastonero S; Gargouri M; Ortiou S; Guéant JL; Merten MD
    J Gene Med; 2005 Nov; 7(11):1439-49. PubMed ID: 16001392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator.
    Trezise AE; Buchwald M
    Nature; 1991 Oct; 353(6343):434-7. PubMed ID: 1716739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic lipid:pDNA complexes for the treatment of cystic fibrosis.
    Eastman SJ; Scheule RK
    Curr Opin Mol Ther; 1999 Apr; 1(2):186-96. PubMed ID: 11715942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cystic fibrosis: molecular update and clinical implications].
    Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
    Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.